Literature DB >> 4402370

A comparison of intravenous pindolol and propranolol in normal man.

D C Hicks, A G Arbab, P Turner, M Hills.   

Abstract

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4402370     DOI: 10.1002/j.1552-4604.1972.tb00164.x

Source DB:  PubMed          Journal:  J Clin Pharmacol New Drugs        ISSN: 0021-9754


× No keyword cloud information.
  11 in total

1.  Comparative beta-adrenoceptor blocking effects and pharmacokinetics of penbutolol and propranolol in man.

Authors:  J F Giudicelli; C Richer; M Chauvin; N Idrissi; A Berdeaux
Journal:  Br J Clin Pharmacol       Date:  1977-04       Impact factor: 4.335

2.  Ocular and cardiovascular effects of local and systemic pindolol.

Authors:  S E Smith; S A Smith; F Reynolds; V B Whitmarsh
Journal:  Br J Ophthalmol       Date:  1979-01       Impact factor: 4.638

3.  Pharmacokinetics of pindolol in man.

Authors:  R Gugler; W Herold; H J Dengler
Journal:  Eur J Clin Pharmacol       Date:  1974       Impact factor: 2.953

4.  Pharmacokinetic and pharmacological studies with tolamolol in man.

Authors:  J K Faulkner; D A Stopher; R Walden
Journal:  Br J Clin Pharmacol       Date:  1975-10       Impact factor: 4.335

5.  A standard approach to compiling clinical pharmacokinetic data.

Authors:  L B Sheiner; L Z Benet; L A Pagliaro
Journal:  J Pharmacokinet Biopharm       Date:  1981-02

Review 6.  Pharmacokinetic properties of the beta-adrenergic receptor blocking drugs.

Authors:  D G Shand
Journal:  Drugs       Date:  1974       Impact factor: 9.546

Review 7.  Beta-adrenergic receptor blocking drugs in hypertension.

Authors:  F O Simpson
Journal:  Drugs       Date:  1974       Impact factor: 9.546

8.  Relationship between plasma concentrations and pharmacological effects of labetalol.

Authors:  D A Richards; J G Maconochie; R E Bland; R Hopkins; E P Woodings; L E Martin
Journal:  Eur J Clin Pharmacol       Date:  1977-01-03       Impact factor: 2.953

Review 9.  Clinical pharmacokinetics of beta-adrenoreceptor blocking drugs.

Authors:  G Johnsson; C G Regàrdh
Journal:  Clin Pharmacokinet       Date:  1976       Impact factor: 6.447

10.  Pindolol pharmacokinetics in relation to time course of inhibition of exercise tachycardia.

Authors:  G L Jennings; A Bobik; E T Fagan; P I Korner
Journal:  Br J Clin Pharmacol       Date:  1979-03       Impact factor: 4.335

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.